Cargando…
Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis
OBJECTIVE: There has been growing evidence that inflammatory markers play a role in the development of type 2 diabetes. We aimed to systematically review prospective studies on the associations of elevated levels of interleukin-6 (IL-6) and C-reactive protein (CRP) with increased risk of type 2 diab...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526249/ https://www.ncbi.nlm.nih.gov/pubmed/23264288 http://dx.doi.org/10.2337/dc12-0702 |
_version_ | 1782253528454004736 |
---|---|
author | Wang, Xia Bao, Wei Liu, Jun OuYang, Ying-Ying Wang, Di Rong, Shuang Xiao, Xiao Shan, Zhi-Lei Zhang, Yan Yao, Ping Liu, Lie-Gang |
author_facet | Wang, Xia Bao, Wei Liu, Jun OuYang, Ying-Ying Wang, Di Rong, Shuang Xiao, Xiao Shan, Zhi-Lei Zhang, Yan Yao, Ping Liu, Lie-Gang |
author_sort | Wang, Xia |
collection | PubMed |
description | OBJECTIVE: There has been growing evidence that inflammatory markers play a role in the development of type 2 diabetes. We aimed to systematically review prospective studies on the associations of elevated levels of interleukin-6 (IL-6) and C-reactive protein (CRP) with increased risk of type 2 diabetes by conducting a meta-analysis. RESEARCH DESIGN AND METHODS: A systematic search of the PubMed, EMBASE, ISI Web of Knowledge, and Cochrane Library databases up until 10 February 2012 was conducted to retrieve prospective studies matched to search terms. We used generalized least-squares trend estimation to assess dose-response relationships. The summary risk estimates were pooled using either fixed-effects or random-effects models to incorporate between-study variation. RESULTS: The meta-analysis, including 10 prospective studies, with a total of 19,709 participants and 4,480 cases, detected a significant dose-response association of IL-6 levels with type 2 diabetes risk (relative risk [RR] 1.31 [95% CI 1.17–1.46]). For CRP, the meta-analysis involving 22 cohorts, with a total of 40,735 participants and 5,753 cases, showed that elevated CRP levels were significantly associated with increased risk of type 2 diabetes (1.26 [1.16–1.37]), with the absence of publication bias. Sensitivity and subgroup analyses further supported the associations. CONCLUSIONS: This meta-analysis provides further evidence that elevated levels of IL-6 and CRP are significantly associated with increased risk of type 2 diabetes. |
format | Online Article Text |
id | pubmed-3526249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-35262492014-01-01 Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis Wang, Xia Bao, Wei Liu, Jun OuYang, Ying-Ying Wang, Di Rong, Shuang Xiao, Xiao Shan, Zhi-Lei Zhang, Yan Yao, Ping Liu, Lie-Gang Diabetes Care Meta-Analysis OBJECTIVE: There has been growing evidence that inflammatory markers play a role in the development of type 2 diabetes. We aimed to systematically review prospective studies on the associations of elevated levels of interleukin-6 (IL-6) and C-reactive protein (CRP) with increased risk of type 2 diabetes by conducting a meta-analysis. RESEARCH DESIGN AND METHODS: A systematic search of the PubMed, EMBASE, ISI Web of Knowledge, and Cochrane Library databases up until 10 February 2012 was conducted to retrieve prospective studies matched to search terms. We used generalized least-squares trend estimation to assess dose-response relationships. The summary risk estimates were pooled using either fixed-effects or random-effects models to incorporate between-study variation. RESULTS: The meta-analysis, including 10 prospective studies, with a total of 19,709 participants and 4,480 cases, detected a significant dose-response association of IL-6 levels with type 2 diabetes risk (relative risk [RR] 1.31 [95% CI 1.17–1.46]). For CRP, the meta-analysis involving 22 cohorts, with a total of 40,735 participants and 5,753 cases, showed that elevated CRP levels were significantly associated with increased risk of type 2 diabetes (1.26 [1.16–1.37]), with the absence of publication bias. Sensitivity and subgroup analyses further supported the associations. CONCLUSIONS: This meta-analysis provides further evidence that elevated levels of IL-6 and CRP are significantly associated with increased risk of type 2 diabetes. American Diabetes Association 2013-01 2012-12-11 /pmc/articles/PMC3526249/ /pubmed/23264288 http://dx.doi.org/10.2337/dc12-0702 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Meta-Analysis Wang, Xia Bao, Wei Liu, Jun OuYang, Ying-Ying Wang, Di Rong, Shuang Xiao, Xiao Shan, Zhi-Lei Zhang, Yan Yao, Ping Liu, Lie-Gang Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis |
title | Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis |
title_full | Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis |
title_fullStr | Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis |
title_full_unstemmed | Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis |
title_short | Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis |
title_sort | inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis |
topic | Meta-Analysis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526249/ https://www.ncbi.nlm.nih.gov/pubmed/23264288 http://dx.doi.org/10.2337/dc12-0702 |
work_keys_str_mv | AT wangxia inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis AT baowei inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis AT liujun inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis AT ouyangyingying inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis AT wangdi inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis AT rongshuang inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis AT xiaoxiao inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis AT shanzhilei inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis AT zhangyan inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis AT yaoping inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis AT liuliegang inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis |